HDAC2 and stroke disorder: Inhibiting HDAC2 using non-selective inhibitors such as MGCD0103, SAHA, and TMP269 was found to promote neuronal survival, suppress neuroinflammation, and improve motor function post-stroke, highlighting the critical role of HDAC2 in recovery [214].